In a two-week randomized trial, 59 adults with chronic nighttime congestion and sleep difficulties used a marketed strip, a prototype, or a sham strip without springs. Both active designs improved some ratings of sleep satisfaction and morning symptoms compared with sham. At day 7, adjusted mean changes in sleep-satisfaction scores on the Pittsburgh Insomnia Rating Scale were −0.7 with the prototype and −0.6 with the marketed strip versus −0.2 with sham (lower scores indicate improvement; both P < .05 versus sham). Benefits were not consistent across every measure or time point. The study found no statistically significant difference between active strips and sham on a separate overall congestion questionnaire. The study excluded people with sleep apnea.

A separate 28-day prototype study in 70 adults also found that participants reported easier breathing and better sleep than at baseline. One measure of brief sleep disruptions improved, but most recorded sleep measures were generally similar with

The 28-day prototype study did not demonstrate an improvement in measured snoring. Researchers measured snore frequency, the proportion of sleep spent snoring, and sound intensity. These results matter because snoring is often the reason someone buys a strip. Easier breathing and a quieter night are separate outcomes, and improvement in one does not establish improvement in the other.

An older study of 11 people with habitual snoring or sleep apnea found less loud snoring and fewer obstructed breaths with a plastic nasal dilator. Ten participants underwent polysomnography with and without the device in randomized order; the reported

Polysomnography is an overnight test that records sleep, breathing, and oxygen levels. A randomized crossover trial in 26 adults with severe obstructive sleep apnea compared strips with CPAP, a treatment that uses air pressure to keep the airway open. Polysomnography on the first intervention night found no statistically significant improvement with strips versus baseline; participants did report less sleepiness at the end of the strip intervention. A second randomized crossover trial compared strips with CPAP in 12 adults with acromegaly, a growth-hormone disorder, and moderate-to-severe apnea. Each treatment period lasted three months; the full-text methods place intervention polysomnography at treatment initiation and symptom questionnaires at the end. That trial found no statistically significant reduction in breathing interruptions per hour with strips, whereas CPAP reduced them. This contrast shows why feeling better cannot confirm that apnea is controlled.

A study of 54 pregnant adults with habitual snoring and higher body weight likewise found no statistically significant change in breathing-event frequency. Median respiratory event index was 5.30 events per hour without strips and 4.80 with strips (interquartile ranges

The two-week sham-controlled trial reported that all strip designs were well tolerated. However, it excluded people with adhesive intolerance, relevant facial skin problems, and major nasal structural abnormalities. That limits reassurance for people whose skin reacts to adhesives. Both congestion studies also selected adults with a relatively narrow, projecting nose shape. Their results need not transfer to every nose shape, healthy sleepers, or every retail design.

Both congestion studies were registered on ClinicalTrials.gov and involved manufacturer-affiliated researchers. The 28-day study was manufacturer-funded. Registration documents a study; it is not independent confirmation of benefit. Short trials also do not establish long-term safety or lasting sleep improvements.

In a two-week randomized trial, 59 adults with chronic nighttime congestion and sleep difficulties used a marketed strip, a prototype, or a sham strip without springs. Both active designs improved some ratings of sleep satisfaction and morning symptoms compared with sham. At day 7, adjusted mean changes in sleep-satisfaction scores on the Pittsburgh Insomnia Rating Scale were −0.7 with the prototype and −0.6 with the marketed strip versus −0.2 with sham (lower scores indicate improvement; both P < .05 versus sham). Benefits were not consistent across every measure or time point. The study found no statistically significant difference between active strips and sham on a separate overall congestion questionnaire. The study excluded people with sleep apnea.

A separate 28-day prototype study in 70 adults also found that participants reported easier breathing and better sleep than at baseline. One measure of brief sleep disruptions improved, but most recorded sleep measures were generally similar with

The 28-day prototype study did not demonstrate an improvement in measured snoring. Researchers measured snore frequency, the proportion of sleep spent snoring, and sound intensity. These results matter because snoring is often the reason someone buys a strip. Easier breathing and a quieter night are separate outcomes, and improvement in one does not establish improvement in the other.

An older study of 11 people with habitual snoring or sleep apnea found less loud snoring and fewer obstructed breaths with a plastic nasal dilator. Ten participants underwent polysomnography with and without the device in randomized order; the reported

Polysomnography is an overnight test that records sleep, breathing, and oxygen levels. A randomized crossover trial in 26 adults with severe obstructive sleep apnea compared strips with CPAP, a treatment that uses air pressure to keep the airway open. Polysomnography on the first intervention night found no statistically significant improvement with strips versus baseline; participants did report less sleepiness at the end of the strip intervention. A second randomized crossover trial compared strips with CPAP in 12 adults with acromegaly, a growth-hormone disorder, and moderate-to-severe apnea. Each treatment period lasted three months; the full-text methods place intervention polysomnography at treatment initiation and symptom questionnaires at the end. That trial found no statistically significant reduction in breathing interruptions per hour with strips, whereas CPAP reduced them. This contrast shows why feeling better cannot confirm that apnea is controlled.

A study of 54 pregnant adults with habitual snoring and higher body weight likewise found no statistically significant change in breathing-event frequency. Median respiratory event index was 5.30 events per hour without strips and 4.80 with strips (interquartile ranges

The two-week sham-controlled trial reported that all strip designs were well tolerated. However, it excluded people with adhesive intolerance, relevant facial skin problems, and major nasal structural abnormalities. That limits reassurance for people whose skin reacts to adhesives. Both congestion studies also selected adults with a relatively narrow, projecting nose shape. Their results need not transfer to every nose shape, healthy sleepers, or every retail design.

Both congestion studies were registered on ClinicalTrials.gov and involved manufacturer-affiliated researchers. The 28-day study was manufacturer-funded. Registration documents a study; it is not independent confirmation of benefit. Short trials also do not establish long-term safety or lasting sleep improvements.